Delivery Order SPE2DB22D9239-SPE2DB25FDL91
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 27, 2025, for EXPAREL 266 mg/20 ml vials valued at $10,042.52. This firm fixed-price delivery order, which has a completion date of September 18, 2025, was issued without a set-aside designation. The award represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $10,550.54 firm fixed-price delivery order on May 12, 2025, by the Defense Logistics Agency's Medical Supply Chain division for the supply of EXPAREL 133 mg/10 ml vials. The award carries an ultimate completion date of June 3, 2025, and does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency valued at $4,873.76 for EXPAREL (liposomal bupivacaine) 133 mg/10 mL vials. The award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency valued at $16,071.40 for EXPAREL 266 mg/20 ml vials. The contract, awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $37,659.45 for the supply of EXPAREL 266 mg/20 mL vials. The award, made on August 25, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $5,021.26 for EXPAREL 1.3% 20ML (10 units) by the Defense Logistics Agency's Medical Supply Chain. The contract was awarded on July 31, 2025, with an ultimate completion date of the same day, and carries no set-aside designation. EXPAREL is a liposomal bupivacaine formulation used for local anesthesia and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, with a ceiling value of $20,085.04. The contract calls for the delivery of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials, a long-acting local anesthetic used in surgical and medical settings. The award carries no set-aside designation and is scheduled for ultimate completion...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,063.78 for EXPAREL 1.3% 20ML (10 units) by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, with the place of performance in Park Ridge, Illinois and an ultimate completion date of September 3, 2025. This award falls under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. This firm fixed-price delivery order carries a ceiling value of $37.4K and represents a task order under the company's larger Indefinite Delivery Contract with DLA valued at $500M through November 2026. The contract requires ultimate...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $25,106.30 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The award carries an ultimate completion date of June 24, 2025, and does not utilize any set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL91Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,092.20 by the Defense Logistics Agency on September 16, 2025. The delivery order covers EXPAREL 133 mg/10 mL vials (10 mL unit) for delivery by October 7, 2025. This award was issued without set-aside designation, leveraging the company's competitive positioning in federal pharmaceutical procurement. The delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a single-award contract valued at $499.999 billion and valid through November 2026, which enables the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. EXPAREL is a liposomal bupivacaine injectable anesthetic commonly used in surgical and medical settings for prolonged local anesthesia. As a Defense Logistics Agency supplier, DMS Pharmaceutical Group distributes branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities. The company's federal contract portfolio demonstrates consistent success in securing pharmaceutical delivery orders across diverse product categories, establishing its role as a critical supplier within the federal pharmaceutical supply chain serving military healthcare infrastructure globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 9/16/25 |